Gujarat State Fertilizers & Chemicals Ltd
Incorporated in 1962, Gujarat State Fertilizers & Chemicals Ltd is a public sector company promoted by the Government of Gujarat. It is engaged in manufacturing of various fertilizers and industrial products like plastics & synthetic rubbers and man-made fibres [1]
- Market Cap ₹ 7,699 Cr.
- Current Price ₹ 193
- High / Low ₹ 322 / 183
- Stock P/E 14.6
- Book Value ₹ 337
- Dividend Yield 2.07 %
- ROCE 5.77 %
- ROE 4.55 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
- Stock is trading at 0.57 times its book value
- Company has been maintaining a healthy dividend payout of 23.6%
Cons
- The company has delivered a poor sales growth of 1.52% over past five years.
- Company has a low return on equity of 7.83% over last 3 years.
- Earnings include an other income of Rs.342 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Fertilizers Industry: Fertilizers
Part of BSE 500 BSE 400 MidSmallCap Index Nifty 500 BSE Allcap BSE Commodities
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2007 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3,317 | 5,386 | 5,311 | 6,108 | 5,265 | 6,266 | 8,491 | 7,798 | 7,634 | 9,085 | 11,369 | 9,155 | 8,771 | |
2,839 | 4,819 | 4,719 | 5,451 | 4,775 | 5,701 | 7,742 | 7,477 | 7,063 | 7,764 | 9,781 | 8,641 | 8,244 | |
Operating Profit | 478 | 567 | 592 | 657 | 489 | 565 | 749 | 321 | 571 | 1,321 | 1,588 | 514 | 527 |
OPM % | 14% | 11% | 11% | 11% | 9% | 9% | 9% | 4% | 7% | 15% | 14% | 6% | 6% |
143 | 120 | 101 | 65 | 61 | 99 | 107 | 105 | 184 | 183 | 152 | 385 | 342 | |
Interest | 76 | 45 | 18 | 31 | 65 | 51 | 61 | 115 | 43 | 10 | 15 | 11 | 12 |
Depreciation | 143 | 145 | 101 | 97 | 104 | 119 | 126 | 171 | 177 | 179 | 182 | 183 | 188 |
Profit before tax | 402 | 496 | 575 | 594 | 382 | 493 | 669 | 141 | 535 | 1,315 | 1,543 | 704 | 670 |
Tax % | 21% | 31% | 30% | 31% | -11% | 4% | 26% | 22% | 16% | 32% | 18% | 20% | |
316 | 349 | 409 | 416 | 424 | 474 | 493 | 110 | 450 | 899 | 1,266 | 564 | 528 | |
EPS in Rs | 7.92 | 8.77 | 10.28 | 10.44 | 10.65 | 11.89 | 12.38 | 2.75 | 11.30 | 22.55 | 31.77 | 14.16 | 13.25 |
Dividend Payout % | 11% | 23% | 21% | 21% | 21% | 18% | 18% | 44% | 19% | 11% | 31% | 28% |
Compounded Sales Growth | |
---|---|
10 Years: | 5% |
5 Years: | 2% |
3 Years: | 6% |
TTM: | -21% |
Compounded Profit Growth | |
---|---|
10 Years: | 5% |
5 Years: | 3% |
3 Years: | 11% |
TTM: | -50% |
Stock Price CAGR | |
---|---|
10 Years: | 6% |
5 Years: | 22% |
3 Years: | 19% |
1 Year: | 6% |
Return on Equity | |
---|---|
10 Years: | 7% |
5 Years: | 7% |
3 Years: | 8% |
Last Year: | 5% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2007 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 |
Reserves | 1,474 | 4,143 | 4,426 | 5,465 | 6,539 | 7,224 | 7,241 | 6,782 | 9,160 | 11,693 | 11,960 | 12,647 | 13,340 |
965 | 789 | 744 | 1,288 | 805 | 1,093 | 1,069 | 1,559 | 37 | 6 | 2 | 5 | 101 | |
876 | 1,571 | 1,250 | 1,558 | 1,666 | 1,918 | 2,074 | 1,702 | 1,887 | 2,347 | 1,867 | 2,319 | 2,368 | |
Total Liabilities | 3,394 | 6,583 | 6,500 | 8,390 | 9,091 | 10,315 | 10,464 | 10,123 | 11,164 | 14,125 | 13,909 | 15,051 | 15,888 |
1,330 | 2,016 | 1,958 | 1,656 | 2,022 | 2,108 | 2,821 | 2,902 | 2,804 | 2,680 | 2,580 | 2,549 | 2,503 | |
CWIP | 6 | 186 | 261 | 405 | 273 | 763 | 187 | 107 | 117 | 158 | 200 | 236 | 464 |
Investments | 338 | 859 | 898 | 1,740 | 2,530 | 2,790 | 2,376 | 2,087 | 4,331 | 6,314 | 5,329 | 6,015 | 6,697 |
1,720 | 3,521 | 3,383 | 4,590 | 4,266 | 4,654 | 5,079 | 5,026 | 3,912 | 4,973 | 5,801 | 6,251 | 6,225 | |
Total Assets | 3,394 | 6,583 | 6,500 | 8,390 | 9,091 | 10,315 | 10,464 | 10,123 | 11,164 | 14,125 | 13,909 | 15,051 | 15,888 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2007 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
429 | 1,575 | 260 | -243 | 911 | 358 | 508 | -8 | 1,783 | 237 | 924 | -268 | |
-28 | -413 | -134 | -173 | -238 | -484 | -281 | -266 | -23 | -18 | -39 | 106 | |
-232 | -938 | -155 | 412 | -656 | 134 | -242 | 267 | -1,559 | -126 | -114 | -403 | |
Net Cash Flow | 169 | 225 | -30 | -4 | 17 | 7 | -15 | -7 | 201 | 92 | 770 | -566 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2007 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 86 | 134 | 133 | 197 | 55 | 54 | 35 | 40 | 22 | 15 | 16 | 20 |
Inventory Days | 99 | 77 | 71 | 56 | 82 | 80 | 106 | 96 | 75 | 95 | 70 | 82 |
Days Payable | 63 | 65 | 39 | 54 | 70 | 76 | 67 | 30 | 40 | 55 | 34 | 50 |
Cash Conversion Cycle | 122 | 146 | 164 | 199 | 67 | 58 | 74 | 105 | 57 | 55 | 52 | 52 |
Working Capital Days | 107 | 115 | 131 | 167 | 177 | 154 | 125 | 162 | 108 | 116 | 92 | 84 |
ROCE % | 20% | 12% | 10% | 6% | 7% | 9% | 3% | 6% | 13% | 13% | 6% |
Documents
Announcements
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
1d - Information on requests for lost share certificates.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
20 Nov - Transcript of Q2 FY25 earnings conference call.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
13 Nov - Audio recording of investor conference call on financial results.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
13 Nov - Newspaper publication of Unaudited financial results for the Quarter ended 30th September, 2024.
-
In-Principle Approval For Investment In Vadodara Jal Sanchay Pvt Ltd ("VJSPL"), Subsidiary Of The Company
12 Nov - Approval for Rs. 28.85 crores investment in VJSPL.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
-
Financial Year 2011
from bse
Concalls
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT REC
-
Feb 2024TranscriptNotesPPT REC
-
Nov 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT REC
-
May 2023Transcript PPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022TranscriptPPT
-
Jul 2022TranscriptPPT
-
May 2021TranscriptPPT
-
Dec 2017TranscriptPPT
Market Leader in Carpolactam
GSFC is a market leader in the value chain of Carpolactam, Nylon 6 virgin polymer and its compounds. The compounds of Nylon 6 are used in diverse performance applications ranging from consumer durables and automotives.[1]